EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of the oral nonpeptide NK-2 receptor antagonist SR48968 on neurokinin A-induced bronchoconstriction in asthmatics



The effect of the oral nonpeptide NK-2 receptor antagonist SR48968 on neurokinin A-induced bronchoconstriction in asthmatics



European Respiratory Journal Supplement 9(23): 289S




(PDF emailed within 1 workday: $29.90)

Accession: 033785750

Download citation: RISBibTeXText



Related references

The effect of the tachykinin NK(2) receptor antagonist MEN11420 (nepadutant) on neurokinin A-induced bronchoconstriction in asthmatics. Therapeutic Advances in Respiratory Disease 3(5): 219-226, 2010

The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. European Respiratory Journal 12(1): 17-23, 1998

The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. American Journal of Respiratory and Critical Care Medicine 153(6 Pt 1): 1781-1784, 1996

Influence of SR48968, a neurokinin NK-2-receptor antagonist, on cough induced by citric acid in conscious guinea-pig. Neuropeptides 26(SUPPL 1): 40, 1994

The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulmonary Pharmacology & Therapeutics 19(6): 413-418, 2005

Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction. Journal of Allergy and Clinical Immunology 111(4): 833-839, 2003

Effect of loratadine--selective antagonist of histamine (H1) receptor--on allergen-induced bronchoconstriction in atopic asthmatics. Pneumonologia i Alergologia Polska 60(11-12): 11-15, 1992

The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction. Pulmonary Pharmacology & Therapeutics 21(2): 276-284, 2007

Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet (North American Edition) 340(8830): 1248-1251, 1992

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models. Pharmacology, Biochemistry, and Behavior 89(1): 36-45, 2007

Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics. American Review of Respiratory Disease 140(5): 1348-1353, 1989

The effect of oral terfenadine on neurokinin-A-induced bronchoconstriction. Journal of Allergy and Clinical Immunology 91(5): 1096-1098, 1993

Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor. Journal of Pharmacology and Experimental Therapeutics 277(2): 900-908, 1996

Effect of BAY x 7195, an oral receptor antagonist of cysteinyl-leukotrienes, on leukotriene D4-induced bronchoconstriction in normal volunteers. European Journal of Clinical Pharmacology 47(3): 227-230, 1994